Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein

Protein Expression and Purification

Volumn 73, Issue 2, 2010, Pages 140-146

  Zhang, Lin ^a   Narayanan, Niju ^a   Brand, Stephen R ^b,d   Nicolette, Charles A ^b   Baroja, Miren ^c   Arp, Jacqueline ^c   Wang, Hao ^c   Moo Young, Murray ^a   Chou, C Perry ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b Argos Therapeutics Inc   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d AGILE SCIENCES   (United States)

Author keywords

CD83; Dendritic cell (DC); Escherichia coli; Gene expression; Protein purification; Therapeutic protein

Indexed keywords

CD83 ANTIGEN; DISULFIDE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SERINE; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DIMERIZATION; ESCHERICHIA COLI; FERMENTATION; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; DIMERIZATION; DISULFIDES; ESCHERICHIA COLI; FERMENTATION; GENETIC VARIATION; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SERINE; VON WILLEBRAND FACTOR;

ESCHERICHIA COLI;

EID: 77955417695     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.05.016     Document Type: Article

References (14)

1. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
2. M. Kruse, O. Rosorius, F. Kratzer, D. Bevec, C. Kuhnt, A. Steinkasserer, G. Schuler, and J. Hauber Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA J. Exp. Med. 191 2000 1581 1589
3. A.T. Prechtel, and A. Steinkasserer CD83: an update on functions and prospects of the maturation marker of dendritic cells Arch. Dermatol. Res. 299 2007 59 69
4. M. Lechmann, D. Krooshoop, D. Dudziak, E. Kremmer, C. Kuhnt, C.G. Figdor, G. Schuler, and A. Steinkasserer The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells J. Exp. Med. 194 2001 1813 1821
5. E. Zinser, M. Lechmann, A. Golka, M.B. Lutz, and A. Steinkasserer Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83 J. Exp. Med. 200 2004 345 351
6. Y. Xu, L. Zhang, W. Yao, S.S. Yedahalli, S. Brand, M. Moo-Young, and C.P. Chou Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein Protein Expr. Purif. 65 2009 92 99
7. M. Lechmann, E. Kremmer, H. Sticht, and A. Steinkasserer Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies Protein Express. Purif. 24 2002 445 452
8. E. Zinser, M. Lechmann, A. Golka, B. Hock, and A. Steinkasserer Determination of the inhibitory activity and biological half-live of soluble CD83: comparison of wild type and mutant isoforms Immunobiology 211 2006 449 453
9. M. Lechmann, N. Kotzor, E. Zinser, A.T. Prechtel, H. Sticht, and A. Steinkasserer CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms Biochem. Biophys. Res. Commun. 329 2005 132 139
10. C.T. Chung, and R.H. Miller Preparation and storage of competent Escherichia coli cells Methods Enzymol. 218 1993 621 627
11. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
12. T.E. Creighton Disulphide bonds between cysteine residues T.E. Creighton, Protein Structure: a Practical Approach 1989 Oxford University Press Oxford 155 167
13. N. Darby, and T.E. Creighton Probing protein folding and stability using disulfide bonds Mol. Biotechnol. 7 1997 57 77
14. W.J. Wedemeyer, E. Welker, M. Narayan, and H.A. Scheraga Disulfide bonds and protein folding Biochemistry 39 2000 4207 4216